XML 53 R43.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock-based Compensation Plans, Performance Based Awards (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 31, 2016
USD ($)
Feb. 29, 2016
USD ($)
shares
Dec. 31, 2015
USD ($)
Employee
shares
Dec. 31, 2016
USD ($)
Director
$ / shares
shares
Jan. 02, 2016
USD ($)
Sep. 30, 2016
USD ($)
$ / shares
shares
Stock Option Activity [Roll Forward]            
Outstanding shares, exercised (in shares) | shares       0    
Stock Options [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Estimated fair value of stock at date of grant $ 211,000          
Share based compensation expense       $ 30,584 $ 0  
Restricted Stock [Member] | Nine Non-Employees [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of employees directors with restricted stock grant | Director       9    
Estimated fair value of stock at date of grant   $ 292,000        
Period for recognition of unearned compensation       12 months    
Share based compensation expense       $ 64,812 0  
Stock Option Activity [Roll Forward]            
Outstanding shares, granted (in shares) | shares   29,700        
Restricted Stock [Member] | Four Employees [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Granted (in shares) | shares     11,540      
Number of employees directors with restricted stock grant | Employee     4      
Estimated fair value of stock at date of grant     $ 116,000      
Period for recognition of unearned compensation     3 years      
Share based compensation expense       $ 9,038 1,665  
Performance Shares [Member]            
Stock Option Activity [Roll Forward]            
Outstanding shares, beginning balance (in shares) | shares       38,460    
Outstanding shares, exercised (in shares) | shares       0    
Outstanding shares, forfeited or expired (in shares) | shares       0    
Outstanding shares, ending balance (in shares) | shares       38,460   38,460
Outstanding shares, exercisable (in shares) | shares       0    
Outstanding shares, vested and expected to vest (in shares) | shares       35,451    
Weighted Average Exercise Price [Abstract]            
Weighted average exercise price, beginning balance (in dollars per share) | $ / shares       $ 9.94    
Weighted average exercise price, exercised (in dollars per share) | $ / shares       0    
Weighted average exercise price, forfeited or expired (in dollars per share) | $ / shares       0    
Weighted average exercise price, ending balance (in dollars per share) | $ / shares       9.94   $ 9.94
Weighted average exercise price, exercisable (in dollars per share) | $ / shares       0    
Weighted average exercise price, vested and expected to vest (in dollars per share) | $ / shares       $ 9.94    
Weighted Average Remaining Contractual Term (Years) [Abstract]            
Weighted average remaining contractual term       3 years 11 months 16 days   4 years 2 months 16 days
Weighted average remaining contractual term, exercised       0 years    
Weighted average remaining contractual term, forfeited or expired       0 years    
Weighted average remaining contractual term, exercisable       0 years    
Weighted average remaining contractual term, vested and expected to vest       3 years 11 months 16 days    
Aggregate Intrinsic Value [Abstract]            
Aggregate intrinsic value, beginning balance       $ 0    
Aggregate intrinsic value, exercised       0    
Aggregate intrinsic value, forfeited or expired       0    
Aggregate intrinsic value, ending balance       0   $ 0
Aggregate intrinsic value, exercisable       0    
Aggregate intrinsic value, vested and expected to vest       $ 0    
Performance Shares [Member] | Executive and Management [Member]            
Stock Option Activity [Roll Forward]            
Outstanding shares, granted (in shares) | shares       0    
Weighted Average Exercise Price [Abstract]            
Weighted average exercise price, granted (in dollars per share) | $ / shares       $ 0    
Weighted Average Remaining Contractual Term (Years) [Abstract]            
Weighted average remaining contractual term, granted       0 years    
Aggregate Intrinsic Value [Abstract]            
Aggregate intrinsic value, granted       $ 0    
Performance Shares [Member] | Nine Non-Employees [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of employees directors with restricted stock grant | Employee     9      
Estimated fair value of stock at date of grant     $ 185,000      
Period for recognition of unearned compensation     3 years      
Share based compensation expense       $ 14,424 $ 2,658